Cargando…
Randomized Mechlorethamine/Chlormethine Induced Dermatitis Assessment Study (MIDAS) Establishes Benefit of Topical Triamcinolone 0.1% Ointment Cotreatment in Mycosis Fungoides
INTRODUCTION: Treatment of early-stage mycosis fungoides (MF) requires safe, skin-directed therapies. Medication side effects can lead to underutilization of effective therapies. The objective of this study was to assess the use of topical triamcinolone 0.1% ointment as a means of reducing contact d...
Autores principales: | Alexander-Savino, Carolina V., Chung, Catherine G., Gilmore, Elaine S., Carroll, Sean M., Poligone, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940998/ https://www.ncbi.nlm.nih.gov/pubmed/35122614 http://dx.doi.org/10.1007/s13555-022-00681-6 |
Ejemplares similares
-
Evaluation and management of patients with early-stage mycosis fungoides who interrupt or discontinue topical mechlorethamine gel because of dermatitis
por: Gilmore, Elaine S., et al.
Publicado: (2020) -
Management of Mycosis Fungoides with Topical Chlormethine/Mechlorethamine Gel: A Columbia University Cutaneous Lymphoma Center Experience
por: GARCIA-SALEEM, Tiffany J., et al.
Publicado: (2021) -
Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data
por: Querfeld, Christiane, et al.
Publicado: (2022) -
The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma
por: Kim, Ellen J., et al.
Publicado: (2021) -
A Little Experience Goes a Long Way: Chlormethine/Mechlorethamine Treatment Duration as a Function of Clinician-Level Patient Volume for Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)—A Retrospective Cohort Study
por: Querfeld, Christiane, et al.
Publicado: (2021)